mustangbio.com (MBIO) Cash Funds per Single Share

Mustang Bio - graphic logo of issuer MBIO

The change in cash per share for Mustang Bio, Inc. (MBIO) on GURU.Markets brings the metric value to 1.88, highlighting the impact of geopolitical disruptions and sanctions on biomaterial logistics. The growth of Mustang Bio, Inc. (MBIO) relies on complex CAR-T patents and strict FDA oversight. High demand for gene therapy necessitates partnerships with pharma behemoths to expand sales markets.

Cash per Single Share: Mustang Bio (MBIO) for 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Mustang Bio, Inc. (MBIO)

- market value and analyst target forecast:
- cash availability and cash flow indicators:
Summary company analysis:Mustang Bio, Inc.
Signature product of Mustang Bio Corp

Cash per share measures the portion of net liquidity attributable to a single security, reflecting the actual capital reserve available to cover operating expenses. By analyzing the cash per share chart for Mustang Bio, Inc. (MBIO), an investor can see the efficiency of the current asset divestiture. The narrowing range of values indicates a stabilization of cash flow during the restructuring period. Transferring trials to academic partners minimizes the risk of a rapid cash burn. This price action confirms the company's transition to an austerity model.

Analysis of competing companies

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Stoke - Cash per Single Share|BLFS: Cash Funds per Single Share|Wave Life Sciences Corp - Cash per Share|Maze Therapeutics, Inc. (MAZE) - Cash per Single Share|Sionna Therapeutics Inc (SION) - Cash Funds per Share|Cash per Single Share Prime Medicine Corp|Cash Funds per Share tayshagtx.com|QURE - Cash Funds Volume per Share|Cash per Single Share MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Cash Funds Volume per Share|Cash per Share SLDB (Solid Biosciences Inc.)|Amount of Cash per Share OCGN|PacBio Corp - Cash per Share|Benitec Biopharma Inc. (BNTC) - Cash per Single Share|DSGN: Cash per Share|Cash Funds per Single Share RCKT|Cash per Single Share FDMT|Cash Funds per Single Share LXEO (Lexeo Therapeutics)|Cash per Share KRRO|Editas Medicine, Inc. - Cash Funds per Single Share|Cash Funds per Share Silence Therapeutics Inc. SLN|Cash per Share ProQR Therapeutics N.V. PRQR|CDXS: Cash per Single Share|Cash Funds Volume per Share Sangamo (SGMO)|NAUT (Nautilus Bio) - Cash per Single Share|MGX - Cash Funds Calculated per Share|DTIL (Precision BioSciences Inc.) - Cash per Share|generationbio.com (GBIO) - Cash Funds Calculated per Share|Cash Funds per Share Boundless Bio Inc (BOLD)|Cash per Share Exicure Inc. (XCUR)|Cash Funds per Share imunon.com IMNN|Cash per Share Phio Pharmaceuticals PHIO|RNAZ - Cash Funds per Share|Amount of Cash per Share BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Cash Funds per Share|Bluebird Bio - Amount of Cash per Share|IPA (ImmunoPrecise Antibodies Ltd) - Cash per Share|Cash on Hand per Share Omega Therapeutics, Inc. OMGA|Cash per Share OMIC|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology